Microbiome-guided cancer immunotherapy: immune mechanisms, resistance pathways, and translational opportunities for precision oncology

Ismail Amin, Atef S. Elgebaly, Hend H. Mohamed, Khaled Abuelhaded, Khaled M. Alam-ElDein, Ahmed Kamel Ibrahim, Shimaa A. Farag, Alaa Adel, Mona Hamdy, Mohamed Elkhawanky, Ahmed Mahdy

Open source

DOI: 10.1007/s12094-026-04500-8
Published: 2026-07-27
Container: Clinical and Translational Oncology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12094-026-04500-8,
  title = {Microbiome-guided cancer immunotherapy: immune mechanisms, resistance pathways, and translational opportunities for precision oncology},
  author = {Ismail Amin and Atef S. Elgebaly and Hend H. Mohamed and Khaled Abuelhaded and Khaled M. Alam-ElDein and Ahmed Kamel Ibrahim and Shimaa A. Farag and Alaa Adel and Mona Hamdy and Mohamed Elkhawanky and Ahmed Mahdy},
  year = {2026},
  journal = {Clinical and Translational Oncology},
  doi = {10.1007/s12094-026-04500-8},
  url = {https://doi.org/10.1007/s12094-026-04500-8}
}

RIS

TY  - JOUR
TI  - Microbiome-guided cancer immunotherapy: immune mechanisms, resistance pathways, and translational opportunities for precision oncology
AU  - Ismail Amin
AU  - Atef S. Elgebaly
AU  - Hend H. Mohamed
AU  - Khaled Abuelhaded
AU  - Khaled M. Alam-ElDein
AU  - Ahmed Kamel Ibrahim
AU  - Shimaa A. Farag
AU  - Alaa Adel
AU  - Mona Hamdy
AU  - Mohamed Elkhawanky
AU  - Ahmed Mahdy
PY  - 2026
JO  - Clinical and Translational Oncology
DO  - 10.1007/s12094-026-04500-8
UR  - https://doi.org/10.1007/s12094-026-04500-8
ER  -

APA

Amin, I., Elgebaly, A. S., Mohamed, H. H., Abuelhaded, K., Alam-ElDein, K. M., Ibrahim, A. K., Farag, S. A., Adel, A., Hamdy, M., Elkhawanky, M., & Mahdy, A. (2026). Microbiome-guided cancer immunotherapy: immune mechanisms, resistance pathways, and translational opportunities for precision oncology. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-026-04500-8

Source records

crossref · retrieved 2026-09-26T07:19:02.009Z